FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2027188051> ?p ?o ?g. }

• W2027188051 endingPage "240" @default.
• W2027188051 startingPage "234" @default.
• W2027188051 abstract "Bone metastasis causes significant pain and morbidity and is characterized by multiple skeletal-related events (SREs), including fractures, spinal cord compression, and the requirement for radiation or surgery to bone. Analysis of such a composite endpoint provides insight into the clinical impact of the disease. However, SREs typically occur in a complex pattern. Recently, zoledronic acid (4 mg) was approved for the treatment of bone metastases secondary to all solid tumors and primary bone lesions from multiple myeloma based on significant benefits from first-event and skeletal morbidity rate analyses. However, multiple-event methods can provide information about the risk of SREs over the entire course of follow-up and address interpatient variation in event rates and temporal trends. Moreover, multiple-event methodology can adjust for survival, which has an effect on SRE incidence. Herein we present a survival-adjusted multiple-event analysis of the cumulative incidence of radiation to bone (a homogenous endpoint) and SREs (a composite endpoint) in 3 large, randomized clinical trials of zoledronic acid (4 mg) in patients with prostate cancer, lung cancer and other solid tumors, or breast cancer. In patients with prostate cancer, zoledronic acid significantly reduced the cumulative incidence of SREs compared with placebo (P = 0.002) as it did among patients with lung cancer and other solid tumors (P = 0.025). In patients with breast cancer, zoledronic acid significantly reduced the cumulative incidence of SREs compared with pamidronate 90 mg over 25 months (P = 0.050). These results are consistent with those obtained using established methods, supporting the validity of the survival-adjusted cumulative mean function for assessing benefits during bisphosphonate therapy." @default.
• W2027188051 created "2016-06-24" @default.
• W2027188051 creator A5033260276 @default.
• W2027188051 creator A5054553011 @default.
• W2027188051 creator A5083726052 @default.
• W2027188051 creator A5089417324 @default.
• W2027188051 date "2005-07-01" @default.
• W2027188051 modified "2023-09-23" @default.
• W2027188051 title "Survival-Adjusted Multiple-Event Analysis for the Evaluation of Treatment Effects of Zoledronic Acid in Patients with Bone Metastases from Solid Tumors" @default.
• W2027188051 cites W1951349736 @default.
• W2027188051 cites W1982915376 @default.
• W2027188051 cites W1986705681 @default.
• W2027188051 cites W1991668450 @default.
• W2027188051 cites W1995227999 @default.
• W2027188051 cites W1996589664 @default.
• W2027188051 cites W2089594482 @default.
• W2027188051 cites W2094187443 @default.
• W2027188051 cites W2104389711 @default.
• W2027188051 cites W2104923745 @default.
• W2027188051 cites W2115871403 @default.
• W2027188051 cites W2131659391 @default.
• W2027188051 cites W2137083298 @default.
• W2027188051 cites W2149876087 @default.
• W2027188051 cites W2159353629 @default.
• W2027188051 cites W2161962336 @default.
• W2027188051 cites W2245364407 @default.
• W2027188051 cites W2320853964 @default.
• W2027188051 cites W4293241248 @default.
• W2027188051 doi "https://doi.org/10.3816/sct.2005.n.017" @default.
• W2027188051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18628179" @default.
• W2027188051 hasPublicationYear "2005" @default.
• W2027188051 type Work @default.
• W2027188051 sameAs 2027188051 @default.
• W2027188051 citedByCount "27" @default.
• W2027188051 countsByYear W20271880512012 @default.
• W2027188051 countsByYear W20271880512013 @default.
• W2027188051 countsByYear W20271880512018 @default.
• W2027188051 countsByYear W20271880512019 @default.
• W2027188051 countsByYear W20271880512021 @default.
• W2027188051 crossrefType "journal-article" @default.
• W2027188051 hasAuthorship W2027188051A5033260276 @default.
• W2027188051 hasAuthorship W2027188051A5054553011 @default.
• W2027188051 hasAuthorship W2027188051A5083726052 @default.
• W2027188051 hasAuthorship W2027188051A5089417324 @default.
• W2027188051 hasConcept C118552586 @default.
• W2027188051 hasConcept C120665830 @default.
• W2027188051 hasConcept C121332964 @default.
• W2027188051 hasConcept C121608353 @default.
• W2027188051 hasConcept C126322002 @default.
• W2027188051 hasConcept C141071460 @default.
• W2027188051 hasConcept C143998085 @default.
• W2027188051 hasConcept C203092338 @default.
• W2027188051 hasConcept C2776256026 @default.
• W2027188051 hasConcept C2776326535 @default.
• W2027188051 hasConcept C2776364478 @default.
• W2027188051 hasConcept C2777783956 @default.
• W2027188051 hasConcept C2778195839 @default.
• W2027188051 hasConcept C2778231337 @default.
• W2027188051 hasConcept C2780192828 @default.
• W2027188051 hasConcept C2780775167 @default.
• W2027188051 hasConcept C530470458 @default.
• W2027188051 hasConcept C535046627 @default.
• W2027188051 hasConcept C61511704 @default.
• W2027188051 hasConcept C71924100 @default.
• W2027188051 hasConcept C72563966 @default.
• W2027188051 hasConcept C88879693 @default.
• W2027188051 hasConceptScore W2027188051C118552586 @default.
• W2027188051 hasConceptScore W2027188051C120665830 @default.
• W2027188051 hasConceptScore W2027188051C121332964 @default.
• W2027188051 hasConceptScore W2027188051C121608353 @default.
• W2027188051 hasConceptScore W2027188051C126322002 @default.
• W2027188051 hasConceptScore W2027188051C141071460 @default.
• W2027188051 hasConceptScore W2027188051C143998085 @default.
• W2027188051 hasConceptScore W2027188051C203092338 @default.
• W2027188051 hasConceptScore W2027188051C2776256026 @default.
• W2027188051 hasConceptScore W2027188051C2776326535 @default.
• W2027188051 hasConceptScore W2027188051C2776364478 @default.
• W2027188051 hasConceptScore W2027188051C2777783956 @default.
• W2027188051 hasConceptScore W2027188051C2778195839 @default.
• W2027188051 hasConceptScore W2027188051C2778231337 @default.
• W2027188051 hasConceptScore W2027188051C2780192828 @default.
• W2027188051 hasConceptScore W2027188051C2780775167 @default.
• W2027188051 hasConceptScore W2027188051C530470458 @default.
• W2027188051 hasConceptScore W2027188051C535046627 @default.
• W2027188051 hasConceptScore W2027188051C61511704 @default.
• W2027188051 hasConceptScore W2027188051C71924100 @default.
• W2027188051 hasConceptScore W2027188051C72563966 @default.
• W2027188051 hasConceptScore W2027188051C88879693 @default.
• W2027188051 hasIssue "4" @default.
• W2027188051 hasLocation W20271880511 @default.
• W2027188051 hasLocation W20271880512 @default.
• W2027188051 hasOpenAccess W2027188051 @default.
• W2027188051 hasPrimaryLocation W20271880511 @default.
• W2027188051 hasRelatedWork W178833663 @default.
• W2027188051 hasRelatedWork W1988873325 @default.
• W2027188051 hasRelatedWork W2027188051 @default.
• W2027188051 hasRelatedWork W2105916193 @default.
• W2027188051 hasRelatedWork W2158771095 @default.

• next